Effects of the COVID-19 Pandemic on Routine Pediatric Vaccine Ordering and Administration — United States, 2020
Jeanne M. Santoli(National Center for Immunization and Respiratory Diseases), Eric Weintraub(University of Maryland, Baltimore), Matthew F. Daley(Kaiser Permanente), Jeanne Tropper, Yoonjae Kang(Centers for Disease Control and Prevention), Malini B. DeSilva(HealthPartners), Megan C. Lindley, Elyse O. Kharbanda(HealthPartners), Tara M. Vogt(National Center for Immunization and Respiratory Diseases), Cameron Noblit(National Center for Immunization and Respiratory Diseases), Lisa Galloway(National Center for Immunization and Respiratory Diseases), Paul Lucas(National Center for Immunization and Respiratory Diseases), Ben Herring(Carter Center), Julianne Gee, Mick Glover(Total (United States))
Cited by 720
Related Papers
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021
|MMWR Morbidity and Mortality Weekly Report|2021|602
Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014--United States.
|PubMed|2014|537
Human Papillomavirus Vaccination Practices: A Survey of US Physicians 18 Months After Licensure
|PEDIATRICS|2010|242
Monitoring the safety of quadrivalent human papillomavirus vaccine: Findings from the Vaccine Safety Datalink
|Vaccine|2011|228
Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices — United States, July 2021
|MMWR Morbidity and Mortality Weekly Report|2021|216